Menu
GeneBe

11-36401243-C-A

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_001160167.2(PRR5L):​c.122C>A​(p.Ala41Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,613,280 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A41T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000033 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000031 ( 0 hom. )

Consequence

PRR5L
NM_001160167.2 missense

Scores

3
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 3.17
Variant links:
Genes affected
PRR5L (HGNC:25878): (proline rich 5 like) Enables ubiquitin protein ligase binding activity. Involved in several processes, including TORC2 signaling; positive regulation of mRNA catabolic process; and regulation of fibroblast migration. Part of TORC2 complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.062958956).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PRR5LNM_001160167.2 linkuse as main transcriptc.122C>A p.Ala41Asp missense_variant 2/9 ENST00000530639.6
PRR5LNM_024841.5 linkuse as main transcriptc.122C>A p.Ala41Asp missense_variant 3/10
PRR5LNM_001160169.1 linkuse as main transcriptc.122C>A p.Ala41Asp missense_variant 1/7
PRR5LNM_001160168.2 linkuse as main transcriptc.3-18012C>A intron_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PRR5LENST00000530639.6 linkuse as main transcriptc.122C>A p.Ala41Asp missense_variant 2/92 NM_001160167.2 P1Q6MZQ0-1

Frequencies

GnomAD3 genomes
AF:
0.0000329
AC:
5
AN:
152114
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.0000440
AC:
11
AN:
249962
Hom.:
0
AF XY:
0.0000591
AC XY:
8
AN XY:
135370
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000868
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000354
Gnomad OTH exome
AF:
0.000491
GnomAD4 exome
AF:
0.0000308
AC:
45
AN:
1461048
Hom.:
0
Cov.:
34
AF XY:
0.0000330
AC XY:
24
AN XY:
726924
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.000157
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000252
Gnomad4 OTH exome
AF:
0.0000828
GnomAD4 genome
AF:
0.0000328
AC:
5
AN:
152232
Hom.:
0
Cov.:
33
AF XY:
0.0000134
AC XY:
1
AN XY:
74444
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.000131
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.000474
Alfa
AF:
0.0000677
Hom.:
0
Bravo
AF:
0.0000416
ExAC
AF:
0.0000165
AC:
2
EpiCase
AF:
0.000164
EpiControl
AF:
0.0000593

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsDec 16, 2021The c.122C>A (p.A41D) alteration is located in exon 2 (coding exon 1) of the PRR5L gene. This alteration results from a C to A substitution at nucleotide position 122, causing the alanine (A) at amino acid position 41 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.27
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.52
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.018
T;.;.;T;T;.;T;.;T;T;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.11
FATHMM_MKL
Benign
0.49
N
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.063
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.81
L;.;.;.;L;.;.;.;.;.;L
MutationTaster
Benign
1.0
N;N;N;N
PrimateAI
Benign
0.39
T
PROVEAN
Benign
-0.76
N;D;N;D;N;D;D;D;D;N;N
REVEL
Benign
0.055
Sift
Uncertain
0.0060
D;D;D;D;D;D;D;D;D;D;D
Sift4G
Uncertain
0.0070
D;D;D;D;D;D;D;D;D;D;D
Polyphen
0.62
P;.;.;.;P;.;.;.;.;.;.
Vest4
0.29
MutPred
0.28
Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);Loss of MoRF binding (P = 0.0656);
MVP
0.30
MPC
0.53
ClinPred
0.048
T
GERP RS
5.2
Varity_R
0.29
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs567974104; hg19: chr11-36422793; API